Allstate Corp Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Allstate Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$65.78 - $105.02 $249,240 - $397,920	-3,789 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$64.07 - $91.75 $242,761 - $347,640	3,789 New	3,789 $259,000
Q4 2020 Feb 12, 2021	SELL	$65.07 - $98.24 $223,190 - $336,963	-3,430 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$59.04 - $77.95 $413 - $545	-7 Reduced 0.2%	3,430 $223,000
Q2 2020 Aug 13, 2020	BUY	$29.01 - $74.23 $99,707 - $255,128	3,437 New	3,437 $251,000

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.62B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Allstate Corp, based on Form 13F filings with the SEC.

Stay updated on Allstate Corp with notifications on news.